aluates Reports

$ 0.0

Automative

Global CXCR4 Antagonists Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-35M5786

Global CXCR4 Antagonists Market Insights Forecast to 2028

BUY CHAPTERS

Global CXCR4 Antagonists Market Insights, Forecast to 2030

Code: QYRE-Auto-35M5786

Report

December 2024

Pages:108

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

BioLineRx Ltd

X4 Pharmaceuticals

Eli Lilly

Roche

Merck

Biokine Therapeutics

GlycoMimetics

Harmonic Pharma

Upsher-Smith Laboratories

CXCR4 Antagonists Market

CXCR4 antagonists are small-molecule which block the CXCR4 receptors and prevent their activation. Blocking the receptors stop the receptors' ligand, CXCL12, from binding which prevent downstream effects. CXCR4 antagonists are especially important for hindering cancer progression because one of the downstream effects initiated by CXCR4 receptor activation is cell movement which lead to tumor growth and metastasis in cancer patients. The CXCR4 receptor has been targeted by antagonistic substances, these antagonists have prospective use as therapeutic drug agents, and are currently under development in labs worldwide.

Market Analysis and Insights: Global CXCR4 Antagonists Market

The global CXCR4 Antagonists market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of CXCR4 Antagonists include Sanofi, BioLineRx, X4 Pharmaceuticals, Eli Lilly, Roche, Merck, Biokine Therapeutics, GlycoMimetics and Harmonic Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

CXCR4 Antagonists is widely used in various fields, such as Cancer, HIV and Chronic Inflammatory Diseases,, etc. Cancer provides greatest supports to the CXCR4 Antagonists industry development. In 2023, global % revenue of CXCR4 Antagonists went into Cancer filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for CXCR4 Antagonists market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of CXCR4 Antagonists, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CXCR4 Antagonists, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CXCR4 Antagonists revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CXCR4 Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CXCR4 Antagonists revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of CXCR4 Antagonists Market Report

Report Metric	Details
Report Name	CXCR4 Antagonists Market
Segment by Type	BL-8040 GMI-1359 Plerixafor (AMD3100) Balixafortide (POL6326) USL311 Others
Segment by Application	Cancer HIV Chronic Inflammatory Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, BioLineRx, X4 Pharmaceuticals, Eli Lilly, Roche, Merck, Biokine Therapeutics, GlycoMimetics, Harmonic Pharma, Upsher-Smith Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CXCR4 Antagonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CXCR4 Antagonists companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CXCR4 Antagonists revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the CXCR4 Antagonists Market report?

Ans: The main players in the CXCR4 Antagonists Market are Sanofi, BioLineRx, X4 Pharmaceuticals, Eli Lilly, Roche, Merck, Biokine Therapeutics, GlycoMimetics, Harmonic Pharma, Upsher-Smith Laboratories

What are the Application segmentation covered in the CXCR4 Antagonists Market report?

Ans: The Applications covered in the CXCR4 Antagonists Market report are Cancer, HIV, Chronic Inflammatory Diseases

What are the Type segmentation covered in the CXCR4 Antagonists Market report?

Ans: The Types covered in the CXCR4 Antagonists Market report are BL-8040, GMI-1359, Plerixafor (AMD3100), Balixafortide (POL6326), USL311, Others

Recommended Reports

Cancer Therapeutics

Targeted Cancer Drugs

Diagnostics & Immunotherapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CXCR4 Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 BL-8040

1.2.3 GMI-1359

1.2.4 Plerixafor (AMD3100)

1.2.5 Balixafortide (POL6326)

1.2.6 USL311

1.2.7 Others

1.3 Market by Application

1.3.1 Global CXCR4 Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Cancer

1.3.3 HIV

1.3.4 Chronic Inflammatory Diseases

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CXCR4 Antagonists Market Perspective (2019-2030)

2.2 Global CXCR4 Antagonists Growth Trends by Region

2.2.1 CXCR4 Antagonists Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 CXCR4 Antagonists Historic Market Size by Region (2019-2024)

2.2.3 CXCR4 Antagonists Forecasted Market Size by Region (2025-2030)

2.3 CXCR4 Antagonists Market Dynamics

2.3.1 CXCR4 Antagonists Industry Trends

2.3.2 CXCR4 Antagonists Market Drivers

2.3.3 CXCR4 Antagonists Market Challenges

2.3.4 CXCR4 Antagonists Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue CXCR4 Antagonists by Players

3.1.1 Global CXCR4 Antagonists Revenue by Players (2019-2024)

3.1.2 Global CXCR4 Antagonists Revenue Market Share by Players (2019-2024)

3.2 Global CXCR4 Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of CXCR4 Antagonists, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global CXCR4 Antagonists Market Concentration Ratio

3.4.1 Global CXCR4 Antagonists Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CXCR4 Antagonists Revenue in 2023

3.5 Global Key Players of CXCR4 Antagonists Head office and Area Served

3.6 Global Key Players of CXCR4 Antagonists, Product and Application

3.7 Global Key Players of CXCR4 Antagonists, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CXCR4 Antagonists Breakdown Data by Type

4.1 Global CXCR4 Antagonists Historic Market Size by Type (2019-2024)

4.2 Global CXCR4 Antagonists Forecasted Market Size by Type (2025-2030)

5 CXCR4 Antagonists Breakdown Data by Application

5.1 Global CXCR4 Antagonists Historic Market Size by Application (2019-2024)

5.2 Global CXCR4 Antagonists Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America CXCR4 Antagonists Market Size (2019-2030)

6.2 North America CXCR4 Antagonists Market Size by Type

6.2.1 North America CXCR4 Antagonists Market Size by Type (2019-2024)

6.2.2 North America CXCR4 Antagonists Market Size by Type (2025-2030)

6.2.3 North America CXCR4 Antagonists Market Share by Type (2019-2030)

6.3 North America CXCR4 Antagonists Market Size by Application

6.3.1 North America CXCR4 Antagonists Market Size by Application (2019-2024)

6.3.2 North America CXCR4 Antagonists Market Size by Application (2025-2030)

6.3.3 North America CXCR4 Antagonists Market Share by Application (2019-2030)

6.4 North America CXCR4 Antagonists Market Size by Country

6.4.1 North America CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America CXCR4 Antagonists Market Size by Country (2019-2024)

6.4.3 North America CXCR4 Antagonists Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe CXCR4 Antagonists Market Size (2019-2030)

7.2 Europe CXCR4 Antagonists Market Size by Type

7.2.1 Europe CXCR4 Antagonists Market Size by Type (2019-2024)

7.2.2 Europe CXCR4 Antagonists Market Size by Type (2025-2030)

7.2.3 Europe CXCR4 Antagonists Market Share by Type (2019-2030)

7.3 Europe CXCR4 Antagonists Market Size by Application

7.3.1 Europe CXCR4 Antagonists Market Size by Application (2019-2024)

7.3.2 Europe CXCR4 Antagonists Market Size by Application (2025-2030)

7.3.3 Europe CXCR4 Antagonists Market Share by Application (2019-2030)

7.4 Europe CXCR4 Antagonists Market Size by Country

7.4.1 Europe CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe CXCR4 Antagonists Market Size by Country (2019-2024)

7.4.3 Europe CXCR4 Antagonists Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China CXCR4 Antagonists Market Size (2019-2030)

8.2 China CXCR4 Antagonists Market Size by Type

8.2.1 China CXCR4 Antagonists Market Size by Type (2019-2024)

8.2.2 China CXCR4 Antagonists Market Size by Type (2025-2030)

8.2.3 China CXCR4 Antagonists Market Share by Type (2019-2030)

8.3 China CXCR4 Antagonists Market Size by Application

8.3.1 China CXCR4 Antagonists Market Size by Application (2019-2024)

8.3.2 China CXCR4 Antagonists Market Size by Application (2025-2030)

8.3.3 China CXCR4 Antagonists Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia CXCR4 Antagonists Market Size (2019-2030)

9.2 Asia CXCR4 Antagonists Market Size by Type

9.2.1 Asia CXCR4 Antagonists Market Size by Type (2019-2024)

9.2.2 Asia CXCR4 Antagonists Market Size by Type (2025-2030)

9.2.3 Asia CXCR4 Antagonists Market Share by Type (2019-2030)

9.3 Asia CXCR4 Antagonists Market Size by Application

9.3.1 Asia CXCR4 Antagonists Market Size by Application (2019-2024)

9.3.2 Asia CXCR4 Antagonists Market Size by Application (2025-2030)

9.3.3 Asia CXCR4 Antagonists Market Share by Application (2019-2030)

9.4 Asia CXCR4 Antagonists Market Size by Region

9.4.1 Asia CXCR4 Antagonists Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia CXCR4 Antagonists Market Size by Region (2019-2024)

9.4.3 Asia CXCR4 Antagonists Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type

10.2.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application

10.3.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country

10.4.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi CXCR4 Antagonists Introduction

11.1.4 Sanofi Revenue in CXCR4 Antagonists Business (2019-2024)

11.1.5 Sanofi Recent Developments

11.2 BioLineRx

11.2.1 BioLineRx Company Details

11.2.2 BioLineRx Business Overview

11.2.3 BioLineRx CXCR4 Antagonists Introduction

11.2.4 BioLineRx Revenue in CXCR4 Antagonists Business (2019-2024)

11.2.5 BioLineRx Recent Developments

11.3 X4 Pharmaceuticals

11.3.1 X4 Pharmaceuticals Company Details

11.3.2 X4 Pharmaceuticals Business Overview

11.3.3 X4 Pharmaceuticals CXCR4 Antagonists Introduction

11.3.4 X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2019-2024)

11.3.5 X4 Pharmaceuticals Recent Developments

11.4 Eli Lilly

11.4.1 Eli Lilly Company Details

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly CXCR4 Antagonists Introduction

11.4.4 Eli Lilly Revenue in CXCR4 Antagonists Business (2019-2024)

11.4.5 Eli Lilly Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche CXCR4 Antagonists Introduction

11.5.4 Roche Revenue in CXCR4 Antagonists Business (2019-2024)

11.5.5 Roche Recent Developments

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck CXCR4 Antagonists Introduction

11.6.4 Merck Revenue in CXCR4 Antagonists Business (2019-2024)

11.6.5 Merck Recent Developments

11.7 Biokine Therapeutics

11.7.1 Biokine Therapeutics Company Details

11.7.2 Biokine Therapeutics Business Overview

11.7.3 Biokine Therapeutics CXCR4 Antagonists Introduction

11.7.4 Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2019-2024)

11.7.5 Biokine Therapeutics Recent Developments

11.8 GlycoMimetics

11.8.1 GlycoMimetics Company Details

11.8.2 GlycoMimetics Business Overview

11.8.3 GlycoMimetics CXCR4 Antagonists Introduction

11.8.4 GlycoMimetics Revenue in CXCR4 Antagonists Business (2019-2024)

11.8.5 GlycoMimetics Recent Developments

11.9 Harmonic Pharma

11.9.1 Harmonic Pharma Company Details

11.9.2 Harmonic Pharma Business Overview

11.9.3 Harmonic Pharma CXCR4 Antagonists Introduction

11.9.4 Harmonic Pharma Revenue in CXCR4 Antagonists Business (2019-2024)

11.9.5 Harmonic Pharma Recent Developments

11.10 Upsher-Smith Laboratories

11.10.1 Upsher-Smith Laboratories Company Details

11.10.2 Upsher-Smith Laboratories Business Overview

11.10.3 Upsher-Smith Laboratories CXCR4 Antagonists Introduction

11.10.4 Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2019-2024)

11.10.5 Upsher-Smith Laboratories Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sanofi

BioLineRx Ltd

X4 Pharmaceuticals

Eli Lilly

Roche

Merck

Biokine Therapeutics

GlycoMimetics

Harmonic Pharma

Upsher-Smith Laboratories

List of Tables

Table 1. Global CXCR4 Antagonists Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of BL-8040

Table 3. Key Players of GMI-1359

Table 4. Key Players of Plerixafor (AMD3100)

Table 5. Key Players of Balixafortide (POL6326)

Table 6. Key Players of USL311

Table 7. Key Players of Others

Table 8. Global CXCR4 Antagonists Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 9. Global CXCR4 Antagonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global CXCR4 Antagonists Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global CXCR4 Antagonists Market Share by Region (2019-2024)

Table 12. Global CXCR4 Antagonists Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global CXCR4 Antagonists Market Share by Region (2025-2030)

Table 14. CXCR4 Antagonists Market Trends

Table 15. CXCR4 Antagonists Market Drivers

Table 16. CXCR4 Antagonists Market Challenges

Table 17. CXCR4 Antagonists Market Restraints

Table 18. Global CXCR4 Antagonists Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global CXCR4 Antagonists Revenue Share by Players (2019-2024)

Table 20. Global Top CXCR4 Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXCR4 Antagonists as of 2023)

Table 21. Global CXCR4 Antagonists Industry Ranking 2022 VS 2023 VS 2024

Table 22. Global 5 Largest Players Market Share by CXCR4 Antagonists Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of CXCR4 Antagonists, Headquarters and Area Served

Table 24. Global Key Players of CXCR4 Antagonists, Product and Application

Table 25. Global Key Players of CXCR4 Antagonists, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global CXCR4 Antagonists Revenue Market Share by Type (2019-2024)

Table 29. Global CXCR4 Antagonists Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global CXCR4 Antagonists Revenue Market Share by Type (2025-2030)

Table 31. Global CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global CXCR4 Antagonists Revenue Share by Application (2019-2024)

Table 33. Global CXCR4 Antagonists Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global CXCR4 Antagonists Revenue Share by Application (2025-2030)

Table 35. North America CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)

Table 36. North America CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)

Table 37. North America CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)

Table 38. North America CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)

Table 39. North America CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)

Table 43. Europe CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)

Table 44. Europe CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)

Table 45. Europe CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)

Table 46. Europe CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Europe CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)

Table 48. Europe CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)

Table 49. China CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)

Table 50. China CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)

Table 51. China CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)

Table 52. China CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)

Table 54. Asia CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)

Table 55. Asia CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)

Table 56. Asia CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)

Table 57. Asia CXCR4 Antagonists Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 58. Asia CXCR4 Antagonists Market Size by Region (2019-2024) & (US$ Million)

Table 59. Asia CXCR4 Antagonists Market Size by Region (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 65. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)

Table 66. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)

Table 67. Sanofi Company Details

Table 68. Sanofi Business Overview

Table 69. Sanofi CXCR4 Antagonists Product

Table 70. Sanofi Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 71. Sanofi Recent Developments

Table 72. BioLineRx Company Details

Table 73. BioLineRx Business Overview

Table 74. BioLineRx CXCR4 Antagonists Product

Table 75. BioLineRx Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 76. BioLineRx Recent Developments

Table 77. X4 Pharmaceuticals Company Details

Table 78. X4 Pharmaceuticals Business Overview

Table 79. X4 Pharmaceuticals CXCR4 Antagonists Product

Table 80. X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 81. X4 Pharmaceuticals Recent Developments

Table 82. Eli Lilly Company Details

Table 83. Eli Lilly Business Overview

Table 84. Eli Lilly CXCR4 Antagonists Product

Table 85. Eli Lilly Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 86. Eli Lilly Recent Developments

Table 87. Roche Company Details

Table 88. Roche Business Overview

Table 89. Roche CXCR4 Antagonists Product

Table 90. Roche Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 91. Roche Recent Developments

Table 92. Merck Company Details

Table 93. Merck Business Overview

Table 94. Merck CXCR4 Antagonists Product

Table 95. Merck Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 96. Merck Recent Developments

Table 97. Biokine Therapeutics Company Details

Table 98. Biokine Therapeutics Business Overview

Table 99. Biokine Therapeutics CXCR4 Antagonists Product

Table 100. Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 101. Biokine Therapeutics Recent Developments

Table 102. GlycoMimetics Company Details

Table 103. GlycoMimetics Business Overview

Table 104. GlycoMimetics CXCR4 Antagonists Product

Table 105. GlycoMimetics Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 106. GlycoMimetics Recent Developments

Table 107. Harmonic Pharma Company Details

Table 108. Harmonic Pharma Business Overview

Table 109. Harmonic Pharma CXCR4 Antagonists Product

Table 110. Harmonic Pharma Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 111. Harmonic Pharma Recent Developments

Table 112. Upsher-Smith Laboratories Company Details

Table 113. Upsher-Smith Laboratories Business Overview

Table 114. Upsher-Smith Laboratories CXCR4 Antagonists Product

Table 115. Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)

Table 116. Upsher-Smith Laboratories Recent Developments

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global CXCR4 Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global CXCR4 Antagonists Market Share by Type: 2023 VS 2030

Figure 3. BL-8040 Features

Figure 4. GMI-1359 Features

Figure 5. Plerixafor (AMD3100) Features

Figure 6. Balixafortide (POL6326) Features

Figure 7. USL311 Features

Figure 8. Others Features

Figure 9. Global CXCR4 Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global CXCR4 Antagonists Market Share by Application: 2023 VS 2030

Figure 11. Cancer Case Studies

Figure 12. HIV Case Studies

Figure 13. Chronic Inflammatory Diseases Case Studies

Figure 14. CXCR4 Antagonists Report Years Considered

Figure 15. Global CXCR4 Antagonists Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global CXCR4 Antagonists Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global CXCR4 Antagonists Market Share by Region: 2023 VS 2030

Figure 18. Global CXCR4 Antagonists Market Share by Players in 2023

Figure 19. Global Top CXCR4 Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXCR4 Antagonists as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by CXCR4 Antagonists Revenue in 2023

Figure 21. North America CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America CXCR4 Antagonists Market Share by Type (2019-2030)

Figure 23. North America CXCR4 Antagonists Market Share by Application (2019-2030)

Figure 24. North America CXCR4 Antagonists Market Share by Country (2019-2030)

Figure 25. United States CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)

Figure 28. Europe CXCR4 Antagonists Market Share by Type (2019-2030)

Figure 29. Europe CXCR4 Antagonists Market Share by Application (2019-2030)

Figure 30. Europe CXCR4 Antagonists Market Share by Country (2019-2030)

Figure 31. Germany CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)

Figure 38. China CXCR4 Antagonists Market Share by Type (2019-2030)

Figure 39. China CXCR4 Antagonists Market Share by Application (2019-2030)

Figure 40. Asia CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)

Figure 41. Asia CXCR4 Antagonists Market Share by Type (2019-2030)

Figure 42. Asia CXCR4 Antagonists Market Share by Application (2019-2030)

Figure 43. Asia CXCR4 Antagonists Market Share by Region (2019-2030)

Figure 44. Japan CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Country (2019-2030)

Figure 54. Brazil CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Sanofi Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 61. BioLineRx Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 62. X4 Pharmaceuticals Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 63. Eli Lilly Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 64. Roche Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 65. Merck Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 66. Biokine Therapeutics Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 67. GlycoMimetics Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 68. Harmonic Pharma Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 69. Upsher-Smith Laboratories Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global IL 23 Receptor Antagonist Market Research Report 2024

Global FLT3 Antagonists Market Research Report 2024

Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CDK4 6 Inhibitors Market Research Report 2024

Global Anti VEGF Therapy for Cancer Market Research Report 2024

Global Integrin Inhibitors Market Research Report 2024

Global VEGFR 2 Inhibitor Market Research Report 2024

Global Androgen Receptor AR Antagonist Market Research Report 2024

Global α4β7 Integrin Antagonists Market Research Report 2024

Global Small Molecule Targeted Anti cancer Drug Market Insights Forecast to 2030

Global Purinergic Receptor Antagonists Market Research Report 2024

Global P2X7 Receptor Antagonists Market Insights Forecast to 2030

Global HER2 Human Epidermal Growth Factor Receptor 2 Inhibitors Market Research Report 2024

Global Checkpoint Inhibitors for Treating Cancer Market Insights Forecast to 2030

Global VEGF Inhibitors for Cancer Market Research Report 2024

Global Epidermal Growth Factor Receptor Inhibitors Market Research Report 2024

Global Immune Checkpoint Inhibitors for Cancer Market Research Report 2024

Global IL 6R Inhibitor Market Research Report 2024

Global Bradykinin Receptor Antagonists Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions